Cell membrane nanoparticles in cancer therapy: From basic structure to surface functionalization
Journal of Controlled Release · 2025-06 · 382 · 113752
DOI: 10.1016/j.jconrel.2025.113752 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Controlled Release, 2025-06. Verfasst von Munsik Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea; Institute of Bioscience & Biotechnology, Kangwo…. Hauptthemen laut MEDLINE: Neoplasms, Cell Membrane, Nanoparticles, Antineoplastic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 135 Literaturangaben. Gefördert von: Kangwon National University, National Research Foundation of Korea.
Abstract (Originalsprache)
Cell membrane nanoparticles (CNPs) have recently garnered significant attention as effective drug-delivery vehicles. Beyond their simple function of encapsulating cargo within a lipid bilayer structure, the cell membrane is a complex entity derived from biological materials, presenting a variety of surface proteins and glycans. Notable features that enhance their effectiveness as delivery vehicles include the inhibition of protein corona formation in the plasma and the suppression of macrophage phagocytosis, both of which contribute to prolonged blood circulation. Furthermore, CNPs exhibit homotypic targeting effects toward their cells of origin, resulting in reduced side effects, and because they are not xenobiotics, the likelihood of nonspecific immune activation is also minimized. This review focuses on various applications of CNPs in cancer therapeutic studies, examining their structural evolution and surface engineering developments. We introduce studies that leverage the inherent functionality of cell membranes and recent research in functional CNPs synthesized through genetic or chemical engineering methods. Through this review, we aim to trace the progression of CNP research, explore potential directions for their use in biomedical applications, and assess the prospects for clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea; Institute of Bioscience & Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea; Department…
- Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
- Department of Medical Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea.
- Department of Chemical and Biomolecular Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea. Electronic address: dohnanyi@kaist.ac.kr.
- Department of Medical Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea; Institute of Bioscience & Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea. Electronic…
Förderung
- Kangwon National University
- National Research Foundation of Korea
Zitieren
APA
Kim, M., Choi, R., Kim, L., Kim, Y. C., & Noh, I. (2025). Cell membrane nanoparticles in cancer therapy: From basic structure to surface functionalization. Journal of Controlled Release, 382, 113752. https://doi.org/10.1016/j.jconrel.2025.113752
Vancouver
Kim M, Choi R, Kim L, Kim YC, Noh I. Cell membrane nanoparticles in cancer therapy: From basic structure to surface functionalization. Journal of Controlled Release. 2025;382:113752. doi:10.1016/j.jconrel.2025.113752
BibTeX
@article{Kim2025,
author = {Kim, Munsik and Choi, Rohbin and Kim, Lian and Kim, Yeu-Chun and Noh, Ilkoo},
title = {Cell membrane nanoparticles in cancer therapy: From basic structure to surface functionalization},
journal = {Journal of Controlled Release},
year = {2025},
volume = {382},
pages = {113752},
doi = {10.1016/j.jconrel.2025.113752}
}
EUVIMED